课题基金 / 基金详情

Colorectal cancer risk after colonoscopy in elderly diabetes patient and men

Colorectal cancer risk after colonoscopy in elderly diabetes patient and men
老年糖尿病患者和男性结肠镜检查后结直肠癌的风险
批准号:
7785904
负责人:
YU-XIAO YANG
金额:
$42.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-07-31

项目摘要

项目成果

YU-XIAO YANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by Applicant): Colorectal cancer (CRC) is the second leading cause of cancer death in the U.S. Colonoscopy is widely used to screen for CRC. Current guidelines recommend screening colonoscopy once every 10 years in average risk patients over >50 year who have no polyps identified at colonoscopy (i.e., negative colonoscopy). However, the prevalence of CRC and polyps increase with age. In addition, nearly 1/4 of the U.S. population over 60 years of age have diabetes mellitus (DM). Recent data suggest patients with diabetes mellitus (DM) have an increased risk of CRC. Furthermore, population-based cancer incidence data have consistently suggested a higher incidence of CRC among men vs. women, and the disparity is most striking among those >65 years. Hence, the negative predictive value of a negative colonoscopy may be lower in patients >65 years who are male or have DM. As a result, there is uncertainty whether the recommended 10-year interval between screening colonoscopies in whom no polyps were identified should apply to elderly men or elderly DM patients. We hypothesize that among patients over the age of 65, the risk of CRC following a negative colonoscopy is higher in men vs. women, and in DM patients vs. non-DM patients. To test this hypothesis, we have designed a population-based cohort study using the linked SEERMedicare data. The study will determine among the SEER-Medicare population, 1) whether men who have undergone a negative colonoscopy have a higher subsequent incidence of CRC than women with a negative colonoscopy; 2) whether DM patients who have undergone a negative colonoscopy have a higher subsequent incidence of CRC than non-DM patients with a negative colonoscopy; 3) whether men or DM patients who have undergone a negative colonoscopy have a lower incidence of CRC than the general SEER-Medicare population who have not undergone colonoscopy and whether the lower incidence persists for up to 10 years; 4) determine the absolute incidence by time of CRC following a colonoscopy without polyps for men, women, all patients with diabetes, men with diabetes, and women with diabetes. Both relative and absolute risks will be examined during the follow-up period. Subgroup analysis will examine the risk for proximal colon cancer and the combined effect of male sex and DM. Relevance to Public Health: CRC is a common cause of death among the elderly population. Screening for colorectal cancer can reduce the risk of cancer and cancer-related mortality. Given the increased incidence of CRC in elderly male patients or elderly DM patients, it is important to determine whether the recommended 10-year interval between colonoscopies without polyps offers adequate protection to these high risk groups. Our study will help establish the appropriate time interval for elderly men and elderly DM patients to undergo a second colonoscopy following a negative colonoscopy so that they will not be facing an unacceptably high rate of preventable CRC morbidity and mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
  • 批准号:
    10216343
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    YU-XIAO YANG
  • 依托单位:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
  • 批准号:
    9293611
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    YU-XIAO YANG
  • 依托单位:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
  • 批准号:
    9600613
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    YU-XIAO YANG
  • 依托单位:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
  • 批准号:
    10201717
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    YU-XIAO YANG
  • 依托单位:
国内基金
海外基金
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
  • 批准号:
    82371223
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    闻大翔
  • 依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
  • 批准号:
    82373139
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李孟鸿
  • 依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
  • 批准号:
    82372089
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李万万
  • 依托单位: